why choose us

First received: August 28, 2023

Clinical Trial: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Postbariatric Hypoglycemia

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Single and Multiple Ascending Dose and Drug Drug Interaction Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Brief Summary: The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses and Drug Drug Interaction of MBX 1416 in healthy volunteersThis study includes 3 parts.Part A involves a single dose of MBX 1416 or placebo taken as a subcutaneous injection (SC).Part B involves repeat doses of MBX 1416 or placebo taken as a subcutaneous injection (SC).Part C involves the evaluation of rosuvastatin and acetaminophen pharmacokinetics in the presence and absence of…

Read more